UBS O'Connor’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $169K | Buy |
+79,000
| New | +$169K | 0.01% | 257 |
|
|
2025
Q1 | – | Sell |
-244,000
| Closed | -$534K | – | 424 |
|
|
2024
Q4 | $534K | Buy |
244,000
+44,000
| +22% | +$96.4K | 0.01% | 267 |
|
|
2024
Q3 | $436K | Buy |
+200,000
| New | +$436K | 0.01% | 337 |
|
|
2024
Q2 | – | Sell |
-134,000
| Closed | -$737K | – | 561 |
|
|
2024
Q1 | $737K | Buy |
+134,000
| New | +$737K | 0.02% | 300 |
|
|
2023
Q4 | – | Sell |
-45,463
| Closed | -$1.58M | – | 547 |
|
|
2023
Q3 | $1.58M | Sell |
45,463
-13,000
| -22% | -$451K | 0.03% | 269 |
|
|
2023
Q2 | $1.92M | Buy |
58,463
+11,437
| +24% | +$375K | 0.04% | 300 |
|
|
2023
Q1 | $1.58M | Buy |
+47,026
| New | +$1.58M | 0.04% | 360 |
|
|
2022
Q4 | – | Sell |
-29,400
| Closed | -$1.03M | – | 322 |
|
|
2022
Q3 | $1.03M | Buy |
+29,400
| New | +$1.03M | 0.01% | 733 |
|